CD BioGlyco Introduces New Polysaccharide Analysis Service to Accelerate Glycobiology Research

PGA Identifies Effective Drugs for Non-responder Cancer Patients

A breakthrough technology PGA brings gene-to-drug revolution in life.

To Fight Superbugs, Ace Infectious Unveils Phage Therapy Development Services

AES Clean Technology expands senior leadership team with key appointment

Montgomeryville, Pennsylvania, January 18, 2024: A leading provider of high-performance cleanroom facilities, AES Clean Technology, has appointed Brian Weed as Chief Revenue Officer (CRO).

Microbialtec: Your One-Stop Solution for Bacillus Genome Editing Needs

1upHealth Commits to Supporting Health Plan Compliance with Latest CMS Interoperability Rule

Creative Biogene Offers High-Quality Biological Fermentation Services to Cater Research and Industrial Needs

Inceptua Group and Cycle Pharmaceuticals Partner for a Free Goods Programme for Patients with Hereditary Tyrosinemia Type 1 (HT-1) and Alkaptonuria (AKU)

Inceptua Group and Cycle Pharmaceuticals Ltd have announced a partnership to make NITYR® Tablets available via a Free Goods Programme for eligible patients with Hereditary Tyrosinemia Type 1 and Alkaptonuria.

Onyx Scientific Targets Stateside Expansion with New Appointment

Onyx Scientific plans to drive forward its latest US expansion plans with the appointment of Anthony Harbour as Business Development Manager in North America

Cleveland Diagnostics Completes $75M Financing to Advance its Early-detection Oncology Testing Platform

Innovative Technology Accurately Detects Cancer Based on Analysis of Changes to Protein Structure Novo Holdings led growth capital financing

Kalderos Names Two Industry Veterans to Executive Leadership Roles

Kalderos Names Two Industry Veterans to Executive Leadership Roles

Alfa Chemistry Integrates Its Supply of Dietary Supplement Ingredients

CD Formulation Excels in Developing and Optimizing Micro-Reservoir Controlled-Release Drug Delivery Systems

Alfa Chemistry Introduces Bio-based Polymers, Responding to Market Demand

BioIVT Fuels Future Cell and Gene Therapy Breakthroughs at Advanced Therapies Week

BioIVT, a global research partner and biospecimen solutions provider for drug and diagnostic development, will exhibit its latest Cell and Gene Therapy (CGT) innovations at Advanced Therapies Week, taking place at the Miami Beach Convention Center from January 16-19.

PharmAlliance Announces Acquisition of Monitor for Hire

Diversified pharmaceutical and life sciences services provider PharmAlliance has acquired Monitorforhire (MFH), the leading web-enabled resource management company connecting professionals with high-impact clinical research opportunities. Operating under BioBridges, PharmAlliance’s talent arm, this acquisition will introduce a new vertical, providing expertise and services to clients and its global network of 4k+ clinical research professionals. Key outcomes include: Bridging Talent Gaps Enhancing Efficiency and Efficacy Strengthening Collaborative Models

Bora Pharmaceuticals to Acquire US Pharma Manufacturer Upsher-Smith for $210 Million in Transaction to Fuel Global Expansion

Sahlgrenska Hospital invests in precision diagnostics with Qlucore Insights

Qlucore has signed an agreement with Sahlgrenska Hospital in Gothenburg, Sweden. The hospital will use the Qlucore Insights software to improve the diagnosis of acute lymphoblastic leukemia (ALL) in children.

Discovery Park Ventures invests £100K in new tenant Vox Imaging Technology to advance ophthalmic imaging for preclinical research

Discovery Park Ventures (DPV) announces an investment of £100K into Vox Imaging Technology Ltd. (VIT), an ambitious ophthalmic technology company looking to transform eye imaging in preclinical research and improve drug discovery and development. Its compact and customisable instrument is believed to be the first scanning laser ophthalmoscope especially designed for laboratory use, able to produce high-quality data rapidly. Vox Imaging is the eighth investment from DPV’s first fund.

Biopharma PEG Unveils Expanded Azide PEG Series

Biopharma PEG, a leading provider of polyethylene glycol (PEG) derivatives, is proud to introduce an extended Azide PEG series that includes monodispersed, polydispersed, and multi-arm PEGs.